Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
Elliott
Jennifer R
JR
Lupus Center of Excellence,University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Manzi
Susan
S
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000188:drug therapy*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011355:Prodrugs; D011446:Prospective Studies; D012074:Remission Induction; D012720:Severity of Illness Index; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D011355:Prodrugs; D003520:Cyclophosphamide; D009173:Mycophenolic Acid